Take care here people. Do your due diligence. The following for example is in the announcement and it implies that the automation process is still some way off:
The completion of primary validation and formal release of the product finalises the development project with AstraZenecaPlc (AstraZeneca). AstraZeneca will now undertake an internal secondary validation of the system within its own manufacturing processes. Completion of AstraZeneca’s secondary validation is anticipated in the third quarter of calendar year 2024. Brent Barnes, CEO & Managing Director said: “Evidence based automation is incredibly important in the biopharmaceutical industry. The completion of our primary validation is a valuable asset to the Company. We expect this data to build confidence in our technology and assist customers with their adoption of APAS® PharmaQC.
I have no connection with this company and don't hold any shares but it has rocketed skywards this morning. I am seeing this type of play (for your money) more and more on the ASX. I hope that I am wrong and it does well.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)